EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Wogonin Attenuates Atherosclerosis via KLF11‐Mediated Suppression of PPARα‐YAP1‐Driven Glycolysis and Enhancement of ABCA1/G1‐Mediated Cholesterol Efflux

Chuanrui Ma iD, Yunqing Hua, Shu Yang, Yun Zhao, Wei Zhang, Yaodong Miao, Jing Zhang, Boxuan Feng, Guobin Zheng, Lan Li, Zhihao Liu, Han Zhang und 3 weitere

Advanced Science · 2025

DOI: 10.1002/advs.202500610 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Advanced Science, 2025. Verfasst von Chuanrui Ma und 14 weiteren Autor:innen. Beteiligte Einrichtung: First Teaching Hospital of Tianjin University of Traditional Chinese Medicine, National Clinical Research Center for Chinese Medicine Acupuncture and…. Hauptthemen laut MEDLINE: Glycolysis, Atherosclerosis, Flavanones, PPAR alpha. Die Arbeit wurde bisher 25-mal zitiert (Crossref) und nennt 111 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China, Natural Science Foundation of Tianjin, Innovation Team and Talents Cultivation Program of National Administration of Traditional Chinese Medicine.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Atherosclerosis, a chronic inflammatory disorder and leading cause of cardiovascular disease, is characterized by macrophage‐derived inflammation and foam cell formation. Emerging evidence suggests that metabolic reprogramming of macrophages represents a promising therapeutic approach for atherosclerosis management. In this study, the therapeutic potential of wogonin, a bioactive flavonoid isolated from Scutellaria baicalensis, in modulating macrophage metabolism and attenuating atherogenesis is investigated. Wogonin reduces lesion size and plaque vulnerability, accompanied by a reduction in foam cell formation and inflammation. Mechanistically, wogonin reprogrammes macrophage metabolism from glycolysis to fatty acid oxidation (FAO) by activating the PPARα‐CPT1α pathway and acts as a mitochondrial protector by activating PPARα. Wogonin also promotes the KLF11 expression and KLF11 knockout exacerbated atherosclerosis and abolishes the inhibitory effect of wogonin on glycolysis and atherosclerosis. KLF11 forms a transcriptional complex with PPARα and YAP1, serving both as a brake on PPARα‐YAP1‐mediated glycolysis and a transcriptional activator of ABCA1/G1. Collectively, wogonin reprograms macrophage metabolism from glycolysis to FAO through activation of the PPARα‐KLF11‐YAP1 pathway, thereby reducing inflammation and foam cell formation, ultimately attenuating atherogenesis.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

GlycolysisAtherosclerosisFlavanonesPPAR alphaCholesterolATP Binding Cassette Transporter 1AnimalsMiceYAP-Signaling ProteinsMacrophagesMice, Inbred C57BLFoam CellsAdaptor Proteins, Signal TransducingTranscription FactorsMaleHumansMice, Knockout

Stichwörter der Autor:innen

KLF11PPARαatherosclerosisfatty acid oxidationmetabolic reprogramming

Substanzen

FlavanonesPPAR alphawogoninYAP-Signaling ProteinsCholesterolATP Binding Cassette Transporter 1Yap1 protein, mouseAdaptor Proteins, Signal TransducingTranscription Factors

Autor:innen und Institutionen

  • First Teaching Hospital of Tianjin University of Traditional Chinese Medicine, National Clinical Research Center for Chinese Medicine Acupuncture and Moxibustion, Tianjin, 300381, China.
  • State Key Laboratory of Component-Based Chinese Medicine, Tianjin, 301617, China.
  • Tianjin Key Laboratory of Translational Research of TCM Prescription and Syndrome, Tianjin, 300381, China.
  • Department of Geriatrics, Peking University Shenzhen Hospital, Shenzhen, China, Shenzhen, Guangdong, 518000, China.
  • Second Affiliated Hospital of Tianjin University of Traditional Chinese Medicine, Tianjin, 300250, P. R. China.
  • NHC Key Laboratory of Hormones and Development, Tianjin Key Laboratory of Metabolic Diseases, Chu Hsien-I Memorial Hospital & Tianjin Institute of Endocrinology, Tianjin Medical University, Tianjin, 300134, China.

ORCID-Profile: Chuanrui Ma

Förderung

  • National Natural Science Foundation of China
  • Natural Science Foundation of Tianjin
  • Innovation Team and Talents Cultivation Program of National Administration of Traditional Chinese Medicine
  • The Science & Technology Development Fund of Tianjin Education Commission for Higher Education
  • The Scientific Research Program of Tianjin Education Commission
  • the second batch of high-level talents in the health industry selection and training project
  • Natural Science Foundation of Tianjin Municipality

Zitieren

APA

Ma, C., Hua, Y., Yang, S., Zhao, Y., Zhang, W., Miao, Y., Zhang, J., Feng, B., Zheng, G., Li, L., Liu, Z., Zhang, H., Zhu, M., Gao, X., & Fan, G. (2025). Wogonin Attenuates Atherosclerosis via KLF11‐Mediated Suppression of PPARα‐YAP1‐Driven Glycolysis and Enhancement of ABCA1/G1‐Mediated Cholesterol Efflux. Advanced Science. https://doi.org/10.1002/advs.202500610

Vancouver

Ma C, Hua Y, Yang S, Zhao Y, Zhang W, Miao Y, et al. Wogonin Attenuates Atherosclerosis via KLF11‐Mediated Suppression of PPARα‐YAP1‐Driven Glycolysis and Enhancement of ABCA1/G1‐Mediated Cholesterol Efflux. Advanced Science. 2025. doi:10.1002/advs.202500610

BibTeX
@article{Ma2025,
  author = {Ma, Chuanrui and Hua, Yunqing and Yang, Shu and Zhao, Yun and Zhang, Wei and Miao, Yaodong and Zhang, Jing and Feng, Boxuan and Zheng, Guobin and Li, Lan and Liu, Zhihao and Zhang, Han and Zhu, Mingjun and Gao, Xiumei and Fan, Guanwei},
  title = {Wogonin Attenuates Atherosclerosis via KLF11‐Mediated Suppression of PPARα‐YAP1‐Driven Glycolysis and Enhancement of ABCA1/G1‐Mediated Cholesterol Efflux},
  journal = {Advanced Science},
  year = {2025},
  doi = {10.1002/advs.202500610}
}
Kostenlos starten →